CGIM
TMO icon

Capital Group Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Capital Group Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.62M Sell
9,208
-880
-9% -$422K 0.7% 40
2026
Q1 		$4.96M Sell
10,088
-2,711
-21% -$1.47M 0.85% 35
2025
Q4 		$7.42M Buy
12,799
+355
+3% +$201K 1.2% 19
2025
Q3 		$6.04M Sell
12,444
-15
-0.1% -$6.98K 1.01% 27
2025
Q2 		$5.05M Sell
12,459
-314
-2% -$131K 0.9% 33
2025
Q1 		$6.36M Buy
12,773
+2,854
+29% +$1.55M 1.3% 20
2024
Q4 		$5.16M Sell
9,919
-987
-9% -$543K 0.98% 27
2024
Q3 		$6.75M Buy
10,906
+72
+0.7% +$42.6K 1.36% 19
2024
Q2 		$5.99M Sell
10,834
-1,066
-9% -$611K 1.29% 19
2024
Q1 		$6.92M Buy
11,900
+1,794
+18% +$1.01M 1.24% 18
2023
Q4 		$5.36M Sell
10,106
-470
-4% -$227K 0.56% 66
2023
Q3 		$5.35M Hold
10,576
– – 0.35% 86
2023
Q2 		$5.52M Buy
10,576
+138
+1% +$74.5K 0.27% 85
2023
Q1 		$6.02M Sell
10,438
-2,127
-17% -$1.2M 0.32% 83
2022
Q4 		$6.92M Buy
+12,565
New +$6.66M 0.27% 88

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Group Investment Management's TMO Position: Q2 2026 in Review

Capital Group Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 8.7% in Q2 2026, selling an estimated $422K and leaving 9,208 shares worth $4.62M. The position accounts for 0.7% of the portfolio, ranked #40.

Capital Group Investment Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.42M in Q4 2025. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital Group Investment Management held 9,208 shares of Thermo Fisher Scientific worth $4.62M as of Q2 2026.
  • Capital Group Investment Management sold 880 Thermo Fisher Scientific shares in Q2 2026, an estimated $422K.
  • Thermo Fisher Scientific made up 0.7% of Capital Group Investment Management's portfolio in Q2 2026, its #40 holding.
  • Capital Group Investment Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Capital Group Investment Management's Thermo Fisher Scientific position peaked at $7.42M in Q4 2025.
  • 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital Group Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.